$SNY
-
Markets
Sanofi’s Duvakitug Shows Promise for Ulcerative Colitis
$SNY Sanofi (NYSE:SNY) and Teva Pharmaceutical Industries have reported encouraging results for their new drug, Duvakitug, in treating ulcerative colitis.…
Read More » -
Markets
Navigating Challenges: European Vaccine Makers Respond to US Political Developments
$SNY European vaccine manufacturers, including Sanofi (NYSE:SNY), are facing increased market pressures following a recent political development in the United…
Read More » -
Markets
Navigating Turbulence: European Vaccine Makers Respond to Political Shifts
$SNY On November 15, European vaccine manufacturers faced a sharp decline in market confidence following President-elect Donald Trump’s announcement of…
Read More »